ENDPOINTS

Taysha’s pivotal trial plans; Keros to stop work on PAH drug, lay off 45% of staff

Taysha’s pivotal trial plans; Keros to stop work on PAH...

May 29, 2025 0

Plus, news about Immunic, Neurocrine Biosciences, Alcon, AusperBio and Evommune:...

Intellia reports case of liver toxicity in ATTR gene editing study

Intellia reports case of liver toxicity in ATTR gene ed...

May 29, 2025 0

Intellia Therapeutics disclosed that one patient in a Phase 3 study of its gene ...

Sanofi’s vaccine tech transfer in Vietnam; Almac’s £1B+ revenue milestone

Sanofi’s vaccine tech transfer in Vietnam; Almac’s £1B+...

May 29, 2025 0

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential ne...

How Illumina’s ex-employees became its customers and competitors

How Illumina’s ex-employees became its customers and co...

May 29, 2025 0

For Illumina, its former employees are both a boon and a problem. In the 27 ...

Merck, Daiichi Sankyo scrap FDA application for HER3 ADC after survival miss

Merck, Daiichi Sankyo scrap FDA application for HER3 AD...

May 29, 2025 0

Merck and Daiichi Sankyo have pulled the biologics license application for their...

FDA rejects Stealth's rare disease drug, but offers potential for accelerated approval

FDA rejects Stealth's rare disease drug, but offers pot...

May 29, 2025 0

After a slight delay, the FDA rejected Stealth BioTherapeutics' Barth syndrome d...

Oric locks down cash for Phase 3 prostate cancer trial with early data in hand

Oric locks down cash for Phase 3 prostate cancer trial ...

May 29, 2025 0

Oric Pharmaceuticals has secured funds to support a planned Phase 3 study of its...

PepGen ditches Duchenne programs after mid-stage fail

PepGen ditches Duchenne programs after mid-stage fail

May 29, 2025 0

PepGen is abandoning its exon 51-skipping Duchenne muscular dystrophy candidate ...

Movement disorder biotech Vima steps onto scene with $60M

Movement disorder biotech Vima steps onto scene with $60M

May 29, 2025 0

Since Bernard Ravina's medical training in neurology in the '90s, there have bee...

Trump axes Moderna bird flu pact worth more than $750M

Trump axes Moderna bird flu pact worth more than $750M

May 29, 2025 0

The Trump administration has killed an award worth $766 million to help Moderna ...

Trump axes Moderna bird flu pacts worth more than $750M

Trump axes Moderna bird flu pacts worth more than $750M

May 28, 2025 0

The Trump administration has killed two awards worth $766 million to help Modern...

Will the FDA approve Moderna's next-gen Covid shot?

Will the FDA approve Moderna's next-gen Covid shot?

May 28, 2025 0

After months of speculation, the US’ stance on Covid-19 vaccines under HHS chief...

Novo Nordisk ‘strongly’ urges US away from pharma tariffs

Novo Nordisk ‘strongly’ urges US away from pharma tariffs

May 28, 2025 0

Novo Nordisk warned the US government not to impose pharma-specific tariffs, but...

Exclusive: Insurance startup Devoted Health cuts 5% of workers in small layoff

Exclusive: Insurance startup Devoted Health cuts 5% of ...

May 28, 2025 0

Devoted Health, the Medicare Advantage insurer with a medical group, has laid of...

Insurance startup Devoted Health cuts 5% of workers in small layoff

Insurance startup Devoted Health cuts 5% of workers in ...

May 28, 2025 0

Devoted Health, the Medicare Advantage insurer with a medical group, has laid of...

GSK, Spero report Phase 3 win for UTI antibiotic; Spero's stock soars

GSK, Spero report Phase 3 win for UTI antibiotic; Spero...

May 28, 2025 0

GSK and Spero Therapeutics announced that a Phase 3 trial for their complicated ...

1
2
3
4

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.